Brother: Testing for lung cancer vaccine

The Center for Cancer Research, UK, has tested more than 1,300 worldwide lung cancer patients with a vaccine called Stimuvax produced by Biomira Biotechnology Company, Canada.

The mechanism of the Stimuvax vaccine is to make the body's immune system ready to attack a chemical called MUC-1 that only appears on the surface of cancer cells. This chemical causes 4 out of 5 cases of cancer.

(Photo: ecanadanow.com) When the Stimuvax vaccine enters the body's immune system, it will be able to destroy cancer cells and not affect other healthy cells.

Scientists at the Center for Cancer Research, UK, conducted a test by half of the patients who participated in the trial will receive treatments that combine surgery, chemotherapy, radiotherapy and vaccines. Please Stimuvax.

Half of the remaining patients only received combined surgical, radiotherapy, chemotherapy and a fake vaccine similar to the Stimuvax vaccine so scientists could compare the results of the two groups. this patient. Before being tested on a large scale, the Stimuvax vaccine has been tested for 171 patients like the above method. 171 of these patients were followed back for follow-up after a few years.

The results showed that the group of patients used fake vaccines, half of them lived 13 months or longer. The group of patients treated with the combination of Stimuvax vaccine, half of them lived 30 months or longer.

If this large-scale trial is positive, the Stimuvax vaccine will be widely circulated for treatment of lung cancer patients worldwide. Scientists are hoping this new Stimuvax vaccine will effectively treat and prolong the life of lung cancer patients especially in the early stages.

In 2003, the UK had more than 37,000 people diagnosed with lung cancer, the death rate remains high.

mystical gem